SCHAFERONE supplier risk profile Q1 2026: China-heavy import base, clean compliance flags, concentrated sourcing.
SCHAFERONE processed 173 shipments in Q1 2026 across 3 suppliers and 3 origin countries. China dominated sourcing with 164 shipments (94.8% of total), followed by Hong Kong and South Korea with 6 and 3 shipments respectively. The importer's entire supply chain channels through HONGKONG MILLEY entities across these three jurisdictions, with the China-based operation accounting for the overwhelming majority of import volume.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
SCHAFERONE shows no matches against sanctions watchlists and reports zero supplier exposure to UFLPA forced-labor indicators. The importer's concentrated supplier base and clean compliance record indicate low flagged risk in Q1 2026.
3 distinct tier-1 suppliers in Q1 2026
| HONGKONG MILLEY | China | 164 |
| HONGKONG MILLEY | Hong Kong SAR China | 6 |
| HONGKONG MILLEY | South Korea | 3 |
Share of Q1 2026 inbound shipments by source country
2 tier-2 + 37 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.